Heron's non-opioid HTX-011 gets Priority Review

By Jennie Walters | Dec 31, 2018 | 10:04 PM GMT

Editor's Note: This article was updated on Jan 2, 2019 at 10:04 PM GMT

FDA accepted and granted Priority Review to an NDA for HTX-011 from Heron Therapeutics Inc.